BACKGROUND: The treatment of chronic subdural hematoma (cSDH) is still charged of significant risk of hematoma recurrence. Patient-related predictors and the surgical procedures themselves have been addressed in many studies. In contrast. postoperative management has infrequently been subjected to detailed analysis. https://ashleyshomestores.shop/product-category/6-piece-power-reclining-sectional/